Halozyme Therapeutics shares owned by Sheets Smith Wealth Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Sheets Smith Wealth Management
from 13F filings
Historical chart of Sheets Smith Wealth Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Sheets Smith Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Sheets Smith Wealth Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $392k | 6.8k | 57.24 |
| 2024-06-30 | $359k | 6.8k | 52.36 |
| 2022-12-31 | $260k | 4.6k | 56.90 |
| 2021-06-30 | $216k | 4.7k | 45.49 |
| 2020-12-31 | $203k | 4.7k | 42.75 |
More positions owned by Sheets Smith Wealth Management
View all positions for Sheets Smith Wealth Management